Niutec AG

Based in Winterthur, Switzerland, and founded in 2000, Niutec AG, a. k. a. Niutec is a private chemical testing laboratory that focuses on providing chemical analysis and development services, including environmental analysis, industrial applications, and medical technology.

In November 2024, GBA Holding GmbH, a portfolio company of Ardian and Quadriga Capital, acquired a majority stake in Niutec AG. Niutec AG specializes in chemical analysis and development services across the sectors of environment, industry, and medical technology. The company provides a wide range of analytical testing services, including environmental assessments, industrial product evaluations, and medical device analysis. Their offerings cater to various applications, such as compliance testing, quality control, and research and development projects.

Niutec's clientele includes businesses from different industries seeking thorough chemical examinations to ensure product safety and regulatory compliance. Niutec AG generates revenue by providing accredited chemical testing services for environmental compliance, industrial safety, and medical device validation, including extractables, leachables and cleanliness assessments. Niutec AG generates revenue through a structured service model that emphasizes independent, accredited laboratory services. Clients typically engage the firm on a project basis, with transactions structured around specific analytical services rendered.

Niutec's pricing structure reflects a fee-for-service model where costs are aligned with the complexity and scope of the analytical tasks. The acquisition of Niutec AG by GBA Group benefits Niutec by expanding its customer base, accelerating innovation, enhancing service offerings and strengthening its position in Swiss environmental and medical testing markets.